Access cutting-edge melanoma treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Hackensack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
Researchers want to learn if V940 with pembrolizumab can stop advanced melanoma from growing or spreading. Melanoma is a type of skin cancer. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. A standard (or usual) treatment for advanced melanoma is immunotherapy. Immunotherapy is a treatment that helps the immune system fight cancer. V940 is a study treatment designed to help a person's immune system attack their specific cancer. Pembrolizumab is
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this melanoma clinical trial in Hackensack, NJ
If you're searching for melanoma treatment options in Hackensack, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.